PTGX stock

Protagonist Therapeutics Inc (PTGX) valuation · rev $46.0M

Protagonist Therapeutics Inc (PTGX) rev $46.0M.

Cached valuation scalars
MetricValue
Market cap$7.25B
Revenue$46.0M
P/S157.7
P/B10.9
These valuation metrics as JSON? API free 100/day

PTGX valuation FAQ

What is PTGX's market cap?

Protagonist Therapeutics Inc (PTGX) market cap is $7.25B on the latest cached fundamentals snapshot.

What is PTGX's latest revenue?

Latest cached Protagonist Therapeutics Inc (PTGX) revenue was $46.0M. Statements: https://lician.com/financials/ptgx

What is PTGX's price-to-sales ratio?

Protagonist Therapeutics Inc (PTGX) price-to-sales (P/S) is 157.7, cached market cap $7.25B divided by revenue $46.0M.

What is PTGX's price-to-book ratio?

Protagonist Therapeutics Inc (PTGX) price-to-book (P/B) is 10.9 on the latest cached fundamentals snapshot.

How many PTGX valuation scalars are listed on this page?

This page lists 4 cached valuation scalars for Protagonist Therapeutics Inc (PTGX): Market cap, Revenue, P/S, and P/B.

Where is PTGX valuation listed?

Cached valuation multiples for Protagonist Therapeutics Inc (PTGX) are listed at https://lician.com/valuation/ptgx.

Not investment advice. Cached rows, not a live tape.